Connection

Makio Ogawa to Fluorouracil

This is a "connection" page, showing publications Makio Ogawa has written about Fluorouracil.
Connection Strength

0.598
  1. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood. 1991 Sep 15; 78(6):1448-51.
    View in: PubMed
    Score: 0.092
  2. CD34 expression by murine hematopoietic stem cells. Developmental changes and kinetic alterations. Ann N Y Acad Sci. 2001 Jun; 938:139-45.
    View in: PubMed
    Score: 0.045
  3. Reversible expression of CD34 by murine hematopoietic stem cells. Blood. 1999 Oct 15; 94(8):2548-54.
    View in: PubMed
    Score: 0.040
  4. Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2. Blood. 1996 Dec 01; 88(11):4124-31.
    View in: PubMed
    Score: 0.033
  5. Modulation of early B lymphopoiesis by interleukin-3. Exp Hematol. 1996 Aug; 24(10):1225-31.
    View in: PubMed
    Score: 0.032
  6. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood. 1996 Jun 01; 87(11):4544-51.
    View in: PubMed
    Score: 0.032
  7. Negative regulation of early T lymphopoiesis by interleukin-3 and interleukin-1 alpha. Blood. 1995 Dec 15; 86(12):4527-31.
    View in: PubMed
    Score: 0.031
  8. Lymphohematopoietic progenitors of normal mice. Blood. 1995 Jun 01; 85(11):3086-92.
    View in: PubMed
    Score: 0.030
  9. The flt3 ligand supports proliferation of lymphohematopoietic progenitors and early B-lymphoid progenitors. Blood. 1995 Apr 01; 85(7):1762-8.
    View in: PubMed
    Score: 0.029
  10. Synergistic interaction between interleukin-12 and steel factor in support of proliferation of murine lymphohematopoietic progenitors in culture. Blood. 1994 Jan 01; 83(1):92-8.
    View in: PubMed
    Score: 0.027
  11. Stage-specific expression of c-kit protein by murine hematopoietic progenitors. Blood. 1993 Oct 15; 82(8):2353-60.
    View in: PubMed
    Score: 0.026
  12. Monoclonal antibody J11d.2 recognizes cell cycle-dormant, primitive hematopoietic progenitors of mice. Blood. 1993 Mar 01; 81(5):1155-60.
    View in: PubMed
    Score: 0.025
  13. Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors. Blood. 1993 Feb 01; 81(3):610-6.
    View in: PubMed
    Score: 0.025
  14. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood. 1992 Jun 01; 79(11):2855-60.
    View in: PubMed
    Score: 0.024
  15. Enrichment of murine marrow cells for progenitors of multilineage hemopoietic colonies. Leukemia. 1992 Mar; 6(3):193-8.
    View in: PubMed
    Score: 0.024
  16. Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood. 1991 Sep 01; 78(5):1223-9.
    View in: PubMed
    Score: 0.023
  17. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc Natl Acad Sci U S A. 1991 Feb 01; 88(3):765-9.
    View in: PubMed
    Score: 0.022
  18. The suppressive effects of type beta transforming growth factor (TGF beta) on primitive murine hemopoietic progenitors are abrogated by interleukin-6 and granulocyte colony-stimulating factor. Leukemia. 1989 Oct; 3(10):687-91.
    View in: PubMed
    Score: 0.020
  19. Granulocyte colony-stimulating factor enhances interleukin 3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A. 1988 May; 85(10):3445-9.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.